Pancreatic Cancer Research

ResearcherGenentechActive in the last 2 years

Mallika Singh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0009-0003-0234-1589; OpenAlex author ID A5057362852. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: 2 papers · 2026: 1 paper

Papers 6

  1. Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer. Last author DOI 10.1038/s41591-026-04537-w↗
  2. A RAS(ON) Multi-Selective Inhibitor Combination Therapy Triggers Long-term Tumor Control through Senescence-Associated Tumor-Immune Equilibrium in Pancreatic D… Co-author DOI 10.1158/2159-8290.cd-24-1425↗
  3. T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Models of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/2159-8290.cd-24-1475↗
  4. Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer. Co-author DOI 10.1038/s41586-024-07379-z↗
  5. Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer. Co-author DOI 10.1038/s41586-024-08084-7↗
  6. Modeling targeted inhibition of MEK and PI3 kinase in human pancreatic cancer. Last author DOI 10.1158/1535-7163.mct-14-0030↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Samantha B. Kemp · 1 shared paper, 2025 · strength 0.21
  2. Margo Orlen · 1 shared paper, 2025 · strength 0.21
  3. Ben Z. Stanger · 1 shared paper, 2025 · strength 0.21
  4. Robert H. Vonderheide · 1 shared paper, 2025 · strength 0.21
  5. Jayne C. McDevitt · 1 shared paper, 2025 · strength 0.21
  6. Caroline Broderick · 1 shared paper, 2025 · strength 0.19
  7. Scott W. Lowe · 1 shared paper, 2025 · strength 0.19
  8. Alexander Starodub · 1 shared paper, 2026 · strength 0.18
  9. Ashenafi Shiferaw Bulle · 1 shared paper, 2026 · strength 0.18
  10. Julien Dilly · 1 shared paper, 2026 · strength 0.18
  11. Wungki Park · 1 shared paper, 2026 · strength 0.18
  12. Ida Aronchik · 1 shared paper, 2026 · strength 0.18
  13. Urszula N. Wasko · 1 shared paper, 2026 · strength 0.18
  14. Andrew J. Aguirre · 1 shared paper, 2026 · strength 0.18
  15. Kian‐Huat Lim · 1 shared paper, 2026 · strength 0.18
  16. Brian Matthew Wolpin · 1 shared paper, 2026 · strength 0.18
  17. Anirban Maitra · 1 shared paper, 2026 · strength 0.18
  18. Minal A. Barve · 1 shared paper, 2026 · strength 0.18
  19. David S. Hong · 1 shared paper, 2026 · strength 0.18
  20. Ignacio Garrido‐Laguna · 1 shared paper, 2026 · strength 0.18
  21. Alexander I. Spira · 1 shared paper, 2026 · strength 0.18
  22. Melissa R. Junttila · 1 shared paper, 2015 · strength 0.04
  23. Klaus P. Hoeflich · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.